TrialJournal of diabetes2025

Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.